opioid epidemic - Page 1 | CARLAT PUBLISHING

Hidden Dangers: The Fentanyl Crisis and Teen Overdose Prevention

March 31, 2025

The Fentanyl overdose crisis is now one of the leading causes of death among adolescents, and it is happening in every corner of the country. Stay with us as we talk about the state of the crisis and the steps we can take to save lives.

Expert Q&A

The State of Opioids on the Street

May 29, 2023

Daniel Ciccarone, MD, MPH

Daniel Ciccarone, MD, MPH.

Justine Miner Professor of Addiction Medicine at the University of California San Francisco.

Dr. Ciccarone is a member of the scientific advisory board for Celero Systems. Relevant financial relationships listed for the author have been mitigated.

Dr. Ciccarone sheds light on the current chaotic and perilous situation surrounding illicit opioids found on the streets.

Supervised Drug Consumption

July 1, 2022

Christopher Clayton, MD, EdM and Deepti Anbarasan, MD.

Christopher L. Clayton, MD, EdM. PGY-4 psychiatry resident, NYU Gorssman School of Medicine, New York, NY.

Deepti Anbarasan, MD. Associate Professor in Psychiatry and Neurology, New York University, New York, NY.

Dr. Clayton and Dr. Anbarasan, authors for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

Supervised Consumption Sites are clinical settings where patients can use drugs in as safe a manner as possible. Clients are supplied with sterile equipment and the clinics are staffed by medical professionals who can respond in the case of an overdose. Once controversial, research clearly shows the benefit of these sites, and they have started opening in the United States.

Supervised Drug Consumption

July 1, 2022

Deepti Anbarasan, MD and Christopher Clayton, MD, EdM

Christopher L. Clayton, MD, EdM. PGY-4 psychiatry resident, NYU Gorssman School of Medicine, New York, NY. Deepti Anbarasan, MD. Associate Professor in Psychiatry and Neurology, New York University, New York, NY.

Dr. Clayton and Dr. Anbarasan, authors for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

Supervised Consumption Sites are clinical settings where patients can use drugs in as safe a manner as possible. Clients are supplied with sterile equipment and the clinics are staffed by medical professionals who can respond in the case of an overdose. Once controversial, research clearly shows the benefit of these sites, and they have started opening in the United States.

Opioid Agonist Treatment and Decreased Mortality

May 1, 2022

David Moltz, MD

David Moltz, MD. Dr. Moltz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Opioid agonist treatments, namely methadone and buprenorphine, save the lives of people with opioid use disorders. In this study, researchers break down how exactly these medications decrease mortality, and it’s not just by reducing overdoses.

Treating Opioid Use Disorder—A Fact Book (2024)

PDF/eBook and CME Access

February 28, 2017

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD, have no financial or other interests in any commercial companies pertaining to this educational activity.

This page has links and instructions for downloading your PDF and eBook copies of Treating Opioid Use Disorder—A Fact Book (2024). All versions of this product include access to the 8 CME Post-Test.

Treating Opioid Use Disorder—A Fact Book (2024)

Print Copy With PDF/eBook and CME Access

February 28, 2017

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD, have no financial or other interests in any commercial companies pertaining to this educational activity.

This page has links and instructions for downloading your PDF and eBook copies of Treating Opioid Use Disorder—A Fact Book (2024). All versions of this product include access to the 8 CME Post-Test.